Tag: ACAD

4 Likely Biotech Takeover Targets To Buy

| July 27, 2016 | 0 Comments
4 Likely Biotech Takeover Targets To Buy

After biotech stock Relypsa was bought out last week for a 60% premium, the odds of M&A heating up in this sector increased dramatically. Bret Jensen shares four more likely takeover targets that should be on your watchlist. It was a good week for the Biotech Gems portfolio. Progenics Pharmaceuticals (NASDAQ: PGNX) leapt 25% in […]

Continue Reading